BRICS Unite to Transform Global TB Eradication Efforts
BRICS countries will deepen cooperation in 2025 to end TB, accounting for over half of global cases. Explore their data-driven push on vaccines, treatments and funding.
GlobalHealth
Read More
How Stephen Hawking Defied ALS Odds for 55 Years
Stephen Hawking beat a three-year ALS prognosis to live 55 years. Neurologist Prof Fan Dongsheng explores what factors might explain his extraordinary resilience.
When Politics Clouds Science: Rethinking COVID-19 Origins
Global search for COVID-19 origins is mired in politics, focusing on China despite evidence of earlier cases elsewhere. Can science prevail over strategy?
China’s NHC Challenges WHO Panel’s Findings on COVID-19 Origins
China’s National Health Commission rejects key sections of the WHO SAGO report on COVID-19 origins, calling it speculative and lacking new evidence.
Medicine Without Borders: CGTN Health Talk on Global ALS Breakthroughs
Neuroscientists from the Chinese mainland, the U.S. and Germany unite on CGTN’s Health Talk to share ALS treatment breakthroughs and push for global cooperation and equitable access.
Tanzanians Honor Chinese Doctor’s Heroic Sacrifice at Muhimbili Hospital
Chinese doctor Zhang Junqiao was honored by over 300 people at Tanzania’s Muhimbili National Hospital after sacrificing his life to save a drowning woman.
Tanzanian Hospital Honors Doctor’s Heroic Sacrifice
Over 300 gathered in Tanzania to honor Chinese doctor Zhang Junqiao, leader of China’s 27th medical aid mission, who died rescuing a drowning woman.
Kennedy Jr. Removes CDC Vaccine Advisers to Restore Trust and Reshape Immunization
U.S. Health Secretary Robert F. Kennedy Jr. fired all 17 members of the CDC’s vaccine advisory committee, aiming to restore public trust and reshape immunization policy.
Chicago Med Students Forge U.S.-China Medical Collaboration
Fifteen University of Chicago med students rotated through Chinese mainland hospitals to boost U.S.-China medical cooperation, forging friendships and research ties.
China Approves First Homegrown Nine-Valent HPV Vaccine
The Chinese mainland greenlights Cecolin 9, its first domestically developed nine-valent HPV vaccine, promising over 98% protection and an easier two-dose schedule for teens.